Pharma & Biotech

Alzamend Neuro's stock experienced a slight uptick in today's trading session, advancing $0.01 or 0.41% to close at $2.44. The...

Institutional confidence in Puma Biotechnology appears to be mounting, as evidenced by substantial position increases from several major investment houses....

Pfizer has secured a critical regulatory milestone, receiving FDA approval for its updated COVID-19 vaccine, COMIRNATY LP.8.1. However, the triumph...

Shares of Adverum Biotechnologies have demonstrated notable technical strength by breaking through a significant short-term indicator, potentially signaling a shift...

Irish biotechnology firm Trinity Biotech is navigating a period of significant challenge and opportunity as it approaches a decisive Nasdaq...

Clene Inc. finds itself at a critical juncture. The biotechnology firm is approaching major regulatory milestones for its lead drug...

Amylyx Pharmaceuticals finds itself in a fight for survival following the complete collapse of its flagship therapy and severe clinical...

Redwire finds itself navigating a complex financial landscape where substantial government contracts contrast sharply with concerning quarterly performance. The space...

Shares of Vera Therapeutics have retreated to a five-day low, reflecting a notable shift in investor sentiment. This pullback coincides...

Shares of BeiGene continued their impressive ascent on the Hong Kong stock exchange, advancing 4.06% today. This gain builds on...